Stock CURLF CURALEAF HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Curaleaf Holdings, Inc. OTC Markets

Equities

CURLF

CA23126M1023

Delayed OTC Markets
Other stock markets
 18:35:31 15/05/2024 BST 		5-day change 1st Jan Change
5.595 USD -4.68% Intraday chart for Curaleaf Holdings, Inc. +5.57% +37.81%
05-10 Needham Adjusts Price Target on Curaleaf to $6.25 From $5.25, Keeps Buy Rating MT
05-10 Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company has insufficient levels of profitability.
  • With an enterprise value anticipated at 4.59 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+37.81% 4.35B -
TRULIEVE CANNABIS CORP. Stock Trulieve Cannabis Corp.
+137.96% 2.21B
C
GOODNESS GROWTH HOLDINGS, INC. Stock Goodness Growth Holdings, Inc.
+147.62% 78.64M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CURA Stock
  4. CURLF Stock
  5. Ratings Curaleaf Holdings, Inc.